drugset / Trial / NCT00017537

Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer

NCT00017537 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have metastatic or recurrent cancer.

Timeline

Start
2000-03
Primary completion
2005-03
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject MVF-HER-2(628-647)-CRL 1005 vaccine Vaccine — Intramuscular